J&J all news related to

J&J suspends COVID vaccine sales forecast on low demand, supply glut

April 20, 2022

Johnson & Johnson on Tuesday (April 19) said it could no longer provide a forecast for sales of its COVID-19 vaccine, as vaccine hesitancy in low-income countries paired with already low demand in higher-income nations has led to a glut of supply.

BioNTech, Moderna and J&J explore omicron versions of covid-19 shots

November 30, 2021

BioNTech, Moderna and Johnson & Johnson are working to adapt their Covid-19 vaccines to address the omicron variant, with the German partner of Pfizer saying it could have a new version ready within 100 days if necessary.

South Africa asks J&J, Pfizer to stop sending vaccines

THURSDAY, NOVEMBER 25, 2021

South Africa asked Johnson & Johnson and Pfizer to suspend delivery of Covid-19 vaccines as it now has enough stock, an illustration of how plunging demand is undermining the countrys rollout ahead of a potential fourth wave of infections.

J&J halts covid-19 vaccine trial because of unexplained illness

TUESDAY, OCTOBER 13, 2020

Johnson & Johnson said its covid-19 vaccine study has been temporarily halted after a clinical trial participant experienced an unexplained illness, the second time that a front-runner developer has paused a trial amid the intensifying race to create a viable immunization against the novel coronavirus.

J&J plans huge vaccine study while Pfizer cites rapid enrollment

FRIDAY, AUGUST 21, 2020

As the race for a covid-19 vaccine gets closer to the finish line, investors are parsing details of trial designs like never before as they handicap which is most likely to succeed.

J&J ordered to pay $4.69 bn damages in talc cancer case

FRIDAY, JULY 13, 2018

US pharmaceutical giant Johnson & Johnson was Thursday ordered to pay out $4.69 billion in damages in a lawsuit representing 22 women and their families who alleged a talc sold by the company contained asbestos and caused them to suffer cancer.